2020 Transferred values declared to VVKT

Transferred values

2020 Disclosing Reports for transfered values

AbbVie, UAB

2021-06-21

AstraZeneca Lietuva, UAB

2021-06-21

Bayer, UAB

2021-06-21

Biogen Lithuania, UAB

2021-06-30

Boehringer Ingelheim RCV GmbH & Co KG Lietuvos filialas

2021-06-21

Egis Pharmaceuticals PLC atstovybė Lietuvoje

2021-06-21

Eli Lilly Lietuva, UAB

2021-06-21

IPSEN Pharma SAS Lietuvos filialas

2021-06-30

Johnson & Johnson, UAB

2021-06-21

Merck Sharp & Dohme, UAB

2021-06-21

Mylan Healthcare, UAB

2021-06-21

Novo Nordisk Pharma, UAB

2021-06-21

Pfizer Luxembourg SARL filialas

2021-06-29

Polpharma, farmacinės įmonės S. A. atstovybė

2021-06-21

Roche Lietuva, UAB

2021-06-21

Sanofi-Aventis Lietuva, UAB

2021-06-21

Servier Pharma, UAB

2021-06-21

SIA Novartis Baltics Lietuvos filialas

2021-07-01

Swixx Biopharma, UAB

2021-08-12

Takeda, UAB

2021-06-21

Takeda, UAB

2021-06-21

Valentis Pharma, UAB

2021-06-21

Companies that had no transferred values during year 2020

Disclosure reports of 2023 transfers of value

Disclosure reports of 2022 transfers of value

Disclosure reports of 2021 transfers of value

Disclosure reports of 2019 transfers of value

Disclosure reports of 2018 transfers of value

Disclosure reports of 2017 transfers of value

Disclosure reports of 2016 transfers of value

Disclosure reports of 2015 transfers of value